Parasite enzyme tested as potential Crohn's disease treatment
NCT ID NCT02281916
Summary
This study tested whether a protein from a parasite could help control inflammation in people with moderate Crohn's disease. Ten patients received three monthly injections of P28GST to check if it was safe and might prevent the disease from returning after surgery. Researchers monitored side effects for a year and looked for changes in inflammation markers and disease activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S ILEOCOLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU, Hôpital Claude Huriez
Lille, 59037, France
-
Centre Hospitalier Dunkerque
Dunkirk, France
-
Centre Hospitalier de Boulogne
Boulogne-sur-Mer, France
-
Centre Hospitalier,
Valenciennes, France
-
Centre hospitalier
Amiens, France
Conditions
Explore the condition pages connected to this study.